Searched for
DIABETES AND OBESITY TREATMENT
Drug-free treatment for diabetes and obesity may become possible as scientists develop a wireless device that detects high blood sugar levels and removes excess sugar from bloodstreamDiabetes treatment news: A team of scientists from France and Switzerland developed a wireless electronic device to manage diabetes. This d...- Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...
- GLP-1 boom in China, India, Brazil could create $22 billion market by 2035, J.P. Morgan saysThe China-India-Brazil market for GLP-1 weight-loss drugs could expand to $22 billion by 2035 from $6.6 billion currently, J.P. Morgan esti...
- Beauty firms chase 'Ozempic face' market as weight-loss drugs boomGalderma, Natura, and L'Oreal are developing treatments for consumers experiencing facial sagging due to rapid weight loss. These companies...
- GLP-1 and fertility: Could weight-loss medicines help women conceive? Here's what new reports revealinsulin resistance can disrupt reproductive hormones. For women with polycystic ovary syndrome (PCOS), ovulation may become irregular. Gett...
- WHO says medicines, surgery not first-line treatment for childhood obesityThe World Health Organization has released guidelines on treating obesity among children and adolescents. It emphasizes structured diets, p...
- From Jab to Pills: Novo Nordisk, Eli Lilly set to take obesity drug battle to IndiaIndia’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...
- 2026 Nobel Prize Predictions: From GLP-1 drugs and CAR-T therapy to gene editing, these breakthroughs could take centre stagePredictions for the 2026 Nobel Prizes in science highlight significant contributions in areas like GLP-1 research and cancer therapies. Car...
- Women tip the scale as weight-loss boom reaches tier-II citiesWhile startups such as General Catalyst-backed Voy and Mumbai-based Metago are seeing higher demand from women, Elevate Now, backed by Tita...
- GLP-1 users are suing over vision loss: What does the evidence really show?Dozens of patients have taken legal action against drug manufacturers, filing personal injury lawsuits that allege they were not adequately...
- Wegovy maker Novo Nordisk faces investor pressure to find growth beyond weight-loss drugsFacing increased scrutiny, Novo Nordisk must clarify its future strategy outside of its leading weight-loss drug. Investors are advocating ...
- W Health Ventures closes second fund at Rs 700 croreThe second fund has so far incubated two companies: cancer-care platform Everhope Oncology, built in partnership with Narayana Health, and ...
- From hunger to obesity: Developing world faces growing threat to child healthChildhood obesity is rapidly increasing in developing nations, creating a significant health challenge. This epidemic is now outpacing unde...
- Eli Lilly’s Mounjaro wins FDA approval for a major new cardiovascular benefitEli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes ...
- UK first in Europe to approve Eli Lilly oral weight loss drugBritain has become the first country in Europe to approve orforglipron, the oral weight loss and diabetes treatment developed by US company...
- Diabesity: It’s more than you thinkThe intertwined rise of obesity and type 2 diabetes, termed 'diabesity,' presents a significant health challenge in India. This condition, ...
- Diabetes type 2, obesity can be treated for long-term cure through same medicine? Details hereWHO's draft guidelines only apply to people with a BMI above 30, in some high-income countries like the United States, the drugs are also r...
- Diabetes in India: Embracing a holistic perspective to combat a growing epidemicDiabetes is a rising health issue in India, with millions affected by the disease and its precursors. Addressing lifestyle factors such as ...
- Eli Lilly's new diabetes drug could boost the stock, says SVB SecuritiesSVB Securities believes that the new diabetes drug by Eli Lilly might be able to address patients' obesity and might lead to more significa...
- How much weight you should lose to keep your diabetes under control? Here is the answer"Treatment of obesity to achieve a sustained loss of 15 per cent body weight has been shown to have a major impact on type 2 diabetes progr...
Load More
